Clinical InvestigationCOPD Predicts Mortality in HF: The Norwegian Heart Failure Registry
Section snippets
Methods
The Norwegian Heart Failure Registry was used. Patients from 26 hospitals with new heart failure, diagnosed between January 2000 and February 2008, were offered inclusion in the registry and were recruited both from in-house and outpatient clinics. Inclusion was done prospectively. Our study was limited to the patients from 22 hospitals for which COPD status (with or without COPD) was available. Data were collected by trained and experienced data collectors using the internationally accepted
Results
COPD status (COPD, n = 699; no COPD, n = 3433) was available for 4132 participants (women, n = 1211 [29%]; men, n = 2921 [71%]) from 22 hospitals. Patients were followed until the last clinical visit or death for a mean follow-up of 13.3 months. Baseline characteristics of the 2 groups are presented in Table 1. Patients' age was similar (COPD, 71 years; no COPD, 70 years; P = .06). Female patients were equally represented in the 2 groups (COPD, 30%; no COPD, 29%; P = .77). Coronary artery
Discussion
This study is, as far as we know, one of the world's largest to evaluate the impact of COPD in HF patients. It shows that COPD has an impact on survival in these patients who are already subject to a high mortality risk. Although there still is a debate on whether COPD is really a risk factor for atherosclerotic events, which was recently shown by Hawkins and colleagues not to be,8 COPD can complicate the diagnosis of HF and interact with its natural history. COPD can sometimes be misdiagnosed
Conclusion
COPD is independently associated with a poorer survival in HF patients. COPD patients are overrated in terms of NYHA class in comparison with other heart failure patients with similar LVEF. Nonetheless, NYHA class remains the strongest predictor of death, suggesting that, even though symptoms might be of a dual cause, they still are a very potent predictor of outcome in these patients.
References (33)
- et al.
COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program
Chest
(2005) - et al.
The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature
Chest
(2005) - et al.
Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes
Am J Cardiol
(2007) - et al.
Predictors of cardiac and noncardiac mortality among 14,697 patients with coronary heart disease
Am J Cardiol
(2003) - et al.
Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure
J Am Coll Cardiol
(2003) - et al.
Impact of chronic obstructive pulmonary disease on long-term outcome of patients hospitalized for heart failure
Am J Cardiol
(2008) - et al.
Clinical, neurohormonal, and inflammatory markers and overall prognostic role of chronic obstructive pulmonary disease in patients with heart failure: data from the Val-HeFT Heart Failure Trial
J Cardiac Failure
(2007) - et al.
Current use of beta blockers in patients with reactive airway disease who are hospitalized with acute coronary syndromes
Am J Cardiol
(2009) - et al.
Effectiveness of beta-blocker therapy after acute myocardial infarction in elderly patients with chronic obstructive pulmonary disease or asthma
J Am Coll Cardiol
(2001) - et al.
Right ventricular ejection fraction: an indicator of increased mortality in patients with congestive heart failure associated with coronary artery disease
J Am Coll Cardiol
(1983)
Early changes of cardiac structure and function in COPD patients with mild hypoxemia
Chest
Comparison of echocardiographic markers of right ventricular function in determining prognosis in chronic pulmonary disease
J Am Soc Echocardiogr
Pulmonary hypertension associated with chronic respiratory disease
Clin Chest Med
Chronic obstructive pulmonary disease
N Engl J Med
Heart failure
N Engl J Med
Importance of chronic obstructive pulmonary disease for prognosis and diagnosis of congestive heart failure in patients with acute myocardial infarction
Eur J Heart Fail
Cited by (68)
Chronic Obstructive Pulmonary Disease and Heart Failure: A Breathless Conspiracy
2022, Cardiology ClinicsCitation Excerpt :At least 5% of the adult population is said to have COPD while the prevalence of HF is perhaps 1% to 2%. Many reports suggest that a large proportion of breathlessness patients have both conditions (Tables 226,29–36 and 337–48). It is worth noting that the diagnosis of “heart failure” includes those with either a reduced (HFrEF) or preserved (HFpEF) left ventricular ejection fraction on imaging, which have a similar prevalence.
Chronic Obstructive Pulmonary Disease and Heart Failure: A Breathless Conspiracy
2020, Heart Failure ClinicsCitation Excerpt :At least 5% of the adult population is said to have COPD while the prevalence of HF is perhaps 1% to 2%. Many reports suggest that a large proportion of breathlessness patients have both conditions (Tables 226,29–36 and 337–48). It is worth noting that the diagnosis of “heart failure” includes those with either a reduced (HFrEF) or preserved (HFpEF) left ventricular ejection fraction on imaging, which have a similar prevalence.
Influence of COPD on outcomes of patients hospitalized with heart failure: Analysis of the Spanish National Hospital Discharge Database (2001–2015)
2018, International Journal of CardiologyImplementation of the Care Bundle for the Management of Chronic Obstructive Pulmonary Disease with/without Heart Failure
2024, Journal of Clinical Medicine
The authors have no conflicts to disclose.